Founder
CurrentFounder, Velzyme, Inc.: Established a biotech start-up dedicated to pioneering treatments for solid cancers.Innovative Research: Identified 10 novel small molecule compounds; currently synthesizing and validating 2 promising candidates.Funding Success: Secured over $200,000 in philanthropic funding and firm commitments exceeding $500,000 from venture capitalists.Strategic Focus: Allocating working capital to enhance drug validation processes and advance pre-clinical trials.